BCL2 and lung carcinoma: They demonstrated that overexpression of miR-181b repressed BCL2 expression as well as increased anti-cancer drug-induced apoptosis in both cell lines, indicating that miR-181b plays a role in the development of multi-drug resistance in both gastric and lung cancer cell-lines by regulating cell death via downregulation of BCL2.